๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Independence of centriole formation and initiation of DNA synthesis in Chinese hamster ovary cells

โœ Scribed by Kuriyama, Ryoko ;Dasgupta, Santanu ;Borisy, Gary G.


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
738 KB
Volume
6
Category
Article
ISSN
0886-1544

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Apoptosis in batch cultures of Chinese H
โœ J. Goswami; A. J. Sinskey; H. Steller; G. N. Stephanopoulos; D. I. C. Wang ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 226 KB ๐Ÿ‘ 2 views

One of the main problems in the culture of Chinese Hamster Ovary (CHO) cells continues to be the inability to maintain the viability of the cultures over an extended period of time. The rapid decline in viability at the end of the culture is exacerbated by the absence of serum. In trying to reduce t

Regulation of polyamine transport in Chi
โœ Timothy L. Byers; Anthony E. Pegg ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 875 KB

Control Chinese hamster ovary (CHO) cells and mutant CHO cells lacking ornithine decarboxylase activity (CHODC-) were used to study the regulation of polyamine uptake. It was found that the transport system responsible for this uptake was regulated by intracellular polyamine levels and that this reg

Cytotoxicity and mutagenicity of 6-amino
โœ F. Sanz; J. M. Pozuelo; A. Santa Maria ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB ๐Ÿ‘ 2 views

A strong teratogen-6-aminonicotinamide (6-AN)-was tested for its ability to induce cytotoxicity and mutagenicity in Chinese hamster ovary (CHO) cells. Tests were performed in the presence and absence of a metabolic activation system (S-9 mix). Cytotoxicity was evaluated in CHO cells by the total pro

Tetracycline-Regulated overexpression of
โœ Pablo Umaรฑa; Joรซl Jean-Mairet; James E. Bailey ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 379 KB ๐Ÿ‘ 2 views

The glycosylation patterns of recombinant therapeutic glycoproteins can be engineered by overexpression of glycosyltransferases in the host cells used for glycoprotein production. Most prior glycosylation engineering experiments have involved constitutive expression of cloned glycosyltransferases. H